Generally-healthy individuals with aberrant bowel movement frequencies show enrichment for microbially-derived blood metabolites associated with reduced kidney function.
Johannes P. Johnson-MartíneziD, Christian DieneriD, Anne E. Levine, Tomasz Maciej WilmanskiiD, David L. SuskindiD, Alexandra RalevskiiD, Jennifer HadlockiD, Andrew T. MagisiD, Leroy HoodiD, Noa RappaportiD, Sean M. GibbonsiD
Abstract
Bowel movement frequency (BMF) has been linked to changes in the composition of the human gut microbiome and to many chronic conditions, like metabolic disorders, neurodegenerative diseases, chronic kidney disease (CKD), and other intestinal pathologies like irritable bowel syndrome and inflammatory bowel disease. Lower BMF (constipation) can lead to compromised intestinal barrier integrity and a switch from saccharolytic to proteolytic fermentation within the microbiota, giving rise to microbially-derived toxins that may make their way into circulation and cause damage to organ systems. However, the connections between BMF, gut microbial metabolism, and the early-stage development and progression of chronic disease remain underexplored. Here, we examined the phenotypic impact of BMF variation in a cohort of generally-healthy, community dwelling adults with detailed clinical, lifestyle, and multi-omic data. We showed significant differences in microbially-derived blood plasma metabolites, gut bacterial genera, clinical chemistries, and lifestyle factors across BMF groups that have been linked to inflammation, cardiometabolic health, liver function, and CKD severity and progression. We found that the higher plasma levels of 3-indoxyl sulfate (3-IS), a microbially-derived metabolite associated with constipation, was in turn negatively associated with estimated glomerular filtration rate (eGFR), a measure of kidney function. Causal mediation analysis revealed that the effect of BMF on eGFR was significantly mediated by 3-IS. Finally, we identify self-reported diet, lifestyle, and psychological factors associated with BMF variation, which indicate several common-sense strategies for mitigating constipation and diarrhea. Overall, we suggest that aberrant BMF is an underappreciated risk factor in the development of chronic diseases, even in otherwise healthy populations.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Microbes regulate glomerular filtration rate in health and chronic kidney disease in mice
Jiaojiao Xu, Eesha Verma, … Jennifer L. Pluznick·Journal of the American Society of NephrologyPeer-reviewed·Jul 29, 2025
- The Dietary Fermentable Fiber Inulin Alters the Intestinal Microbiome and Improves Chronic Kidney Disease Mineral-Bone Disorder in a Rat Model of CKD
S. M. Moe, A. Biruete, … M. A. Allen·bioRxiv·Jan 29, 2023
- Host, diet, microbiome, and xenobiotic plasma metabolites associate with kidney cell-type transcriptional programs in CKD
Farrhin Nowshad, Meltem Su, Leah T. C. Guthrie·bioRxiv·Jun 16, 2026
- Long-term fasting remodels gut microbial metabolism and host metabolism
Q. R. Ducarmon, F. Grundler, … Robin Mesnage·bioRxiv·Apr 19, 2024
- The Impact of Uremia and Intestinal Dysbiosis on Hepatic Drug Metabolism in a Rat Model of Progressive Chronic Kidney Disease
Emily D Hartjes, Yong Jin Lim, … Bradley L Urquhart·bioRxiv·Jan 29, 2019
- Gut environmental factors explain variations in the gut microbiome composition and metabolism within and between healthy adults
Nicola Procházková, Martin Frederik Laursen, … Henrik Munch Roager·Nature MicrobiologyPeer-reviewed·Nov 27, 2024